Resources

Cardiovascular diseases are a global health crisis, with hypertension as a significant risk factor. ...

Mayo Clinic Digital Health selects Corsano Cardiowatch suitable for use in generally healthy, community-dwelling ...

We were proud to present at the Medtronic Acute Care & Monitoring (ACM) Western Europe FY26 Kick-Off Meeting.

The Ghent hospital Maria Middelares is the first hospital in Belgium to use Corsano ...

Sepsis is a critical medical emergency frequently associated with significant organ failure and high ...

The medically-certified multi-parameter wearable designed for continuous monitoring of vital signs enhances the Medtronic portfolio of patient monitoring solutions.

Corsano system presentation by Marjolein Muller

In this prospective study, authors assessed the performance of the PPG sensor technology of ...

The early detection of clinical deterioration could be the next significant step in enhancing ...

Assessment of Physiological Signals from Photoplethysmography Sensors Compared to an Electrocardiogram Sensor: A Validation ...

Survival from out-of-hospital cardiac arrest depends on immediate recognition and early cardiopulmonary resuscitation. Especially ...

Hypothalamic dysfunction may not only cause obesity, but also causes chronic fatigue and headaches, ...

The Synthetic hEalthcare dAta goveRnanCe Hub (SEARCH) aims to accelerate healthcare innovation by generating ...

Corsano launched commercialization of its CardioWatch EU-MDR certified patient monitoring bracelet on cobas® pulse, ...

We are thrilled to announce that our CEO Peter Stas presented Corsano Health's innovative ...

Corsano Health is announcing that its CardioWatch 287-2 System received FDA Clearance.

The occurrence of exacerbations has major effects on the health of people with chronic ...

Collaborating researchers from Reinier de Graaf Hospital have validated the Corsano cuffless photoplethysmography-based wristband ...

Collaborating researchers from Radboud University Medical Center, Erasmus MC, Reinier de Graaf Hospital, and ...

Cisco and Corsano closely collaborated on the new Cisco Platform for In-Hospital Monitoring of ...

Radboud University Medical Center (RadboudUMC) has initiated a donation campaign to support the DETECT ...

A Use Case Paper on the Role of the Corsano CardioWatch in Digital Transformation ...

Pharmacovigilance, often referred to as "pharma vigilance," involves the activities related to the detection, ...

Collaborating researchers from Radboud University Medical Center, Erasmus MC, Reinier de Graaf Hospital, and ...

Students had Corsano CardioWatch 287-2 on their wrists, providing them with a practical opportunity ...

Hypertension increases cardiovascular risk. Measuring reliable blood pressure (sBP and dBP for systolic and ...

This validation study showed that the Corsano 287 CardioWatch/Bracelet with PPG-technology can determine HR ...

The fully remote, investigator-initiated Smartphone and Corsano Health’s CardioWatch 287 wearable detected atrial arrhythmia ...

Chronic hypertension is a significant risk factor for cardiovascular diseases (CVD) [1]. However, obtaining ...

Automated cardiac arrest detection and alarming is a potential solution to shorten treatment delays ...

Recent studies suggest that atrial fibrillation (AF) burden (time AF is present) is an ...

Respiration rate is an important physiological parameter whose abnormality has been regarded as an ...

Comparison measured steps per minute determined by the Cardiowatch with steps per minute determined ...

A total of 41 (19 female and 22 male) adults in good cardiovascular health ...

Regulations and standards put the emphasis on usability and human factor design in the ...

Screening for atrial fibrillation and timely initiation of oral anticoagulation, rhythm management, and treatment ...

70 patients in an AF rhythm and 70 patients in sinus rhythm were recruited. ...

Corsano’s sleep analysis is powered by Philips Wearable Sensing algorithms. This clinical trial is ...

The Army Combat Fitness Test (ACFT) is a performance assessment used by the U.S. ...

Patients with interstitial lung disease (ILD) require regular assessment of functional capacity and oxygen ...

Targeted therapies such as osimertinib and alectinib, used to treat EGFR- and ALK-mutated non-small ...

Reliable heart rate (HR) monitoring in children is essential for both diagnostic and therapeutic monitoring in pediatric cardiology.

Peak oxygen uptake (VO₂ max) is a key measure of cardiorespiratory fitness, yet its ...

Wearable devices are increasingly used to monitor physical activity in clinical and research settings, ...

Patients with haematological malignancies undergoing inpatient treatment, such as immunochemotherapy or stem cell transplantation, ...

Sepsis is a life-threatening condition arising from a dysregulated immune response to infection, leading ...

Investigation of Corsano CardioWatch 287-2B devices for monitoring Elhers-Danlos Syndrome (EDS) patient physiology in ...

Investigation of Corsano CardioWatch 287-2B devices for monitoring and maintaining peak cognitive performance levels ...

Improving health outcomes in areas such as early identification of infection, individual vaccine responses, ...

The Corsano system for early Sepsis detection (CORSEP) trial. A collaborative trial between Universitätsmedizin ...

RR will be obtained by FDA cleared Reference Device General Electric® Carescape B850 cleared ...

Out-of-hospital cardiac arrest (OHCA) is a leading cause of global mortality. Delays to initiation ...

Wearables have the potential to monitor patients remotely. The Corsano CardioWatch 287-2 is such ...

MULTI-VITAL Multi Parameter Vital Signs Monitoring by the Corsano Cardiowatch 287-2 Validation Study

Investigating the potential of Corsano Cardiowatch 287 monitoring bracelet in monitoring patients with Chronic ...

An observational study in patients between 12 and 70 years old with an acute ...

Evaluation of the performance and efficacy of the Corsano Cardiowatch 287 Bracelet in measuring ...

A phase I/II, multicenter study evaluating the feasibility, safety, and efficacy of point-of-care manufactured ...

Evaluation of the performance of the Corsano Cardiowatch 287 Bracelet in identifying AF episodes ...

The present study is looking for calibration and accuracy of SpO2, Pulse Rate and ...

The first 1000 days of life reflect the period from the 3 months before ...

To study the feasibility, efficacy and performance of the Corsano CardioWatch 287 module with ...

Vital sign changes often precede cardiac arrest, unexpected death, or ICU admission. If observed ...

To demonstrate that patients with previously unknown atrial arrhythmias can be detected by a ...

Obesity is a global epidemic. Obesity is associated with an increased risk of atrial ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia and a major risk factor ...

The number of cardiac patients with obesity is rising, however their number of referral ...

In this study, we try to investigate the impact of air quality and green-blue ...

The first 1000 days of life reflect the period from the 3 months before ...

In this prospective single-center trial, a wearable photoplethysmographic (PPG) sensor coupled with a cloud ...

Bone metastases represent a common complication in cancer patients, particularly in advanced stages of ...

Continuous and accurate respiration rate monitoring offers vital insights into respiratory health,
enabling ...

Blood pressure (BP) is a vital indicator of cardiovascular health, and its frequent and ...

Dr. Eelko Ronner PhD presented study findings from a collaboration with Reinier de Graaf ...

August 28, 2023, the Research Team of Reinier de Graaf Hospital presented results of ...

Corsano Health is launching the company’s CardioWatch EU-MDR certified patient monitoring bracelet with Cuffless ...

Sepsis is a life-threatening emergency. Under the leadership of Dr. Matthias Gründling, SepsisDialog has ...

Corsano’s CardioWatch EU-MDR certified patient monitoring bracelet will connect to cobas® pulse, Roche’s digitally ...

Corsano Health is launching the company’s second-generation EU-MDR wearable device that accurately measures eight ...

Revolutionizing the use of patient centric data in correlating effective clinical outcomes.

This technology should save thousands of lives: recognise cardiac arrests and sound an alarm. ...

As the benefits of remote patient monitoring (RPM) grow increasingly evident, wearable devices emerge ...

Corsano Health CardioWatch in Radboudumc Cardiac Arrest Clinical Trial
Every year, approximately 17,000 ...

Notified Body DARE!! Services B.V. declares that it has audited the quality assurance system ...

We are happy to announce that Corsano Health B.V. is medically certified complying with ...

The accuracy of Corsano CardioWatch 287 with pulse detection using photoplethysmography technology in cardiac ...

High blood pressure (hypertension) is a common condition in which the long-term force of ...

Sepsis is a life-threatening condition characterized by a dysregulated immune response to infection, leading ...

The most common cardiac arrhythmia is atrial fibrillation (AF). One in four will get ...

Telemetry rhythm surveillance is standard of care for a large subgroup of hospitalized cardiac ...

Corsano has medically certified it’s new software platform under ISO 13485 and EU-MDR. Latest ...

The ABPM scenario focuses on the impact of using one medical bracelet instead of ...

Corsano’s CardioWatch 287-2 is a transformative solution for hypertension monitoring, highlighting its potential to replace traditional 24-hour ABPM.

Atrial arrhythmias in older adults present significant healthcare challenges. This paper evaluates the efficacy ...

We are proud to announce that the Dutch Heart Foundation awarded Corsano Health a ...